Search

everythinglearnresearchcommunity

for

Search:↓

The study suggests fibrosing alopecia in a pattern distribution has distinct features and may vary by race.

Researchers developed a method to label and study human hair follicle stem cells using a fluorescent protein.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

FP-1 is a key protein in rat hair growth, active only during the growth phase.

Human cells in plasma-derived gels can potentially mimic hair follicle environments, improving hair regeneration therapies.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Hair transplants can trigger a rare scarring hair loss that is hard to treat.

Red dots on the upper chest may be an early sign of certain types of hair loss.

Perifollicular erythema can indicate active frontal fibrosing alopecia.

Cystic panfolliculoma resembles hair follicle tumors due to specific cell interactions.

Fos protein is crucial for cell transition to cornification in keratinized tissues.

Researchers found a new early sign of Frontal Fibrosing Alopecia that could help avoid misdiagnosis.

DP and DS cells are different from DF cells in structure and function.

Fibrosing alopecia can be stabilized or improved with anti-inflammatory treatments and hair growth agents.

Canine dermal papilla cells and fibroblasts have distinct growth patterns and protein expressions.

FFA patients have fewer melanocytes and thinner skin compared to others.

Autofluorescence in hair follicle stem cells can interfere with studies but may help isolate these cells.

Fibrosing alopecia in a pattern distribution is a new type of scarring hair loss that resembles common baldness and an autoimmune skin disease.

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

Men with male pattern baldness have higher levels of A-FABP, which might help in early detection.

Higher FABP4 levels may help diagnose androgenetic alopecia early.

Fibrosing alopecia starts earlier in Latin American men and often looks like common male pattern baldness.

Researchers identified potential markers for human hair color stem cells.

HFMs can help study hair growth and test potential hair growth drugs.

Fibroblasts can be mistaken for neural cells, so functional validation is needed.

Focal atrichia helps diagnose female pattern hair loss.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

The document concludes that treatment can improve hair growth and symptoms in Fibrosing Alopecia in a Pattern Distribution.

The study suggests a possible increase in androgen receptors in patients with frontal fibrosing alopecia, but more research is needed.